Physician profile
Thomas J Devito
NPI 1609896026
$2,201.59
in general payments reported to CMS, 2019-2025
20 companies · $275 in 2025
The $275 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $332 · 2022: $630 · 2023: $388 · 2024: $575 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,239.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $502.62 | 2022-2025 | Watchman Flx |
| Esperion Therapeutics, INC. | $206.34 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $203.33 | 2021-2024 | Farxiga, Brilinta |
| Sanofi-Aventis U.S. LLC | $195.17 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $161.65 | 2022-2025 | Jardiance |
| Novo Nordisk INC | $146.64 | 2025 | Ozempic, Wegovy |
| Pfizer INC. | $140.38 | 2022-2025 | |
| Actelion Pharmaceuticals US, INC. | $125.00 | 2021 | |
| Irhythm Technologies, INC. | $92.96 | 2024 | Zio Monitor, Zio Xt Patch |
| Janssen Pharmaceuticals, INC | $85.61 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $76.63 | 2021-2024 | |
| Amgen INC. | $48.47 | 2022-2024 | Repatha |
| Heartflow, INC. | $48.19 | 2023-2024 | Ffrct |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $43.94 | 2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $38.71 | 2023-2024 | Eliquis |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $21.33 | 2022 | |
| Kestra Medical Technology Services, INC. | $19.89 | 2024 | Assure Wcd |
| Philips North America LLC | $17.30 | 2023 | |
| Angiodynamics, INC. | $13.78 | 2023 | Angiovac |
| Lexicon Pharmaceuticals, INC. | $13.65 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Devito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.